Your session is about to expire
← Back to Search
Web Technology for Opioid Addiction
N/A
Waitlist Available
Led By Lisa Marsch, PhD
Research Sponsored by National Development and Research Institutes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults (>/= 18 years)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will test whether an interactive, computer-based system can help opioid-dependent patients in office-based buprenorphine treatment.
Who is the study for?
This trial is for adults over 18 years old who are dependent on opioids and currently in their first month of buprenorphine maintenance treatment at an office-based setting. It's not open to those who are using buprenorphine as part of a tapering-off process.Check my eligibility
What is being tested?
The study is testing the effectiveness and cost-efficiency of a computer-based educational tool designed to support patients undergoing treatment for opioid addiction with buprenorphine, which is a medication used to treat opioid dependence.See study design
What are the potential side effects?
While this trial focuses on web technology rather than medication, typical side effects from buprenorphine can include nausea, headaches, drowsiness, constipation, or withdrawal-like symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
opiate use
Secondary outcome measures
HIV risk behavior
feedback on intervention
opiate craving
+3 moreFind a Location
Who is running the clinical trial?
National Development and Research Institutes, Inc.Lead Sponsor
37 Previous Clinical Trials
12,856 Total Patients Enrolled
Lisa Marsch, PhDPrincipal InvestigatorNational Development and Research Institutes, Inc.
2 Previous Clinical Trials
136 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently reducing my opioid use with buprenorphine.I am in my first month of buprenorphine treatment.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible to still join this experiment?
"The trial in question, which was initially posted on December 1st 2004 and last edited 8/11/2008 is not accepting candidate applications at present. Despite this, 291 distinct clinical trials are presently seeking patient volunteers."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger